One year ago, we began raising funds for the Myeloma Crowd Research Iniatiive. With the help of an expert Scientific Advisory Board and a knowledgeable Patient Advisory Board, we selected two projects to fund: 1) a CAR T Cell research project targeting CS1 and BCMA from Drs. Hermann Einsele and Michael Hudecek from the University of Würzburg in Germany and 2) a T cell immunotherapy using marrow infiltrating lymphocytes (MILs) with transplant from Dr. Ivan Borrello of Johns Hopkins.
We've now provided an initial $100,000 to each research project. In this episode, Dr. Michael Hudecek gives us an update of his CAR T cell research from the grant award that the Myeloma Crowd Research Initiative has provided. Learn more about what we've done with YOUR support to help advance a cure in this important episode.